Giuseppe
Emeritus
[Source: The Lancet Infectious Diseases, full page: (LINK). Extract.]
The Lancet Infectious Diseases, Early Online Publication, 17 November 2013
doi:10.1016/S1473-3099(13)70299-8
Copyright ? 2013 Elsevier Ltd All rights reserved.
Antibiotic Action: helping deliver action plans and strategies
Original Text
Laura JV Piddock a
________
The Lancet Infectious Diseases Commission on antibiotic resistance and use1 provides a global overview of antibiotic resistance, the paucity of new drugs to treat multidrug-resistant bacterial infections, and some of the key issues and proposals to resolve the present difficulties. Insufficient understanding of the complex and myriad reasons for the crisis of antibiotic resistance and scarcity of new treatments has complicated and compounded the predicament. For these reasons, the British Society for Antimicrobial Chemotherapy (BSAC) public engagement initiative Antibiotic Action was launched in November 2011,2 to inform and educate everyone about the need for discovery, research, and development of new treatments for bacterial infections. The initiative contributes to national and international activities, and acts as a conduit for the sharing of information about antibiotic resistance and paucity of new drugs with all stakeholders.
(?)
________
a Institute of Microbiology and Infection and School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
-
-------
The Lancet Infectious Diseases, Early Online Publication, 17 November 2013
doi:10.1016/S1473-3099(13)70299-8
Copyright ? 2013 Elsevier Ltd All rights reserved.
Antibiotic Action: helping deliver action plans and strategies
Original Text
Laura JV Piddock a
________
The Lancet Infectious Diseases Commission on antibiotic resistance and use1 provides a global overview of antibiotic resistance, the paucity of new drugs to treat multidrug-resistant bacterial infections, and some of the key issues and proposals to resolve the present difficulties. Insufficient understanding of the complex and myriad reasons for the crisis of antibiotic resistance and scarcity of new treatments has complicated and compounded the predicament. For these reasons, the British Society for Antimicrobial Chemotherapy (BSAC) public engagement initiative Antibiotic Action was launched in November 2011,2 to inform and educate everyone about the need for discovery, research, and development of new treatments for bacterial infections. The initiative contributes to national and international activities, and acts as a conduit for the sharing of information about antibiotic resistance and paucity of new drugs with all stakeholders.
(?)
________
a Institute of Microbiology and Infection and School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
-
-------